JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joo, H. S.
Right arrow Articles by Honey, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joo, H. S.
Right arrow Articles by Honey, R. J.
Related Collections
Right arrow Pain
Right arrow Pharmacology
Anesth Analg 2001;93:1227-1232
© 2001 International Anesthesia Research Society


ANESTHETIC PHARMACOLOGY

A Comparison of Patient-Controlled Sedation Using Either Remifentanil or Remifentanil-Propofol for Shock Wave Lithotripsy

Hwan S. Joo, MD FRCPC*, William J. Perks, Phm{dagger}, Mark T. Kataoka, MD FRCPC*, Lee Errett, MD FRCSC{ddagger}, Kenneth Pace, MD FRCSC§, and R. John Honey, MD FRCSC§

Departments of *Anaesthesia and {dagger}Pharmacy, Divisions of {ddagger}Cardiac Surgery and §Urology, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

Address correspondence to Hwan Joo, MD, Department of Anaesthesia, St. Michael’s Hospital, University of Toronto, 30 Bond St., Toronto, Ontario, Canada M5B 1W8. Address e-mail to hwanjoom{at}yahoo.com

Patient-controlled sedation (PCS) has been used for extracorporeal shock wave lithotripsy (SWL) because it allows for rapid individualized titration of anesthetics. Because of its sedating effects, the addition of propofol to remifentanil may improve patient tolerance of SWL with PCS. One hundred twenty patients were randomly assigned to receive remifentanil 10 µg or remifentanil 10 µg plus propofol 5 mg for PCS with zero-lockout interval. Nine patients in the Remifentanil group and three patients in the Remifentanil-Propofol group required additional sedatives to complete their SWL (P = 0.128). Compared with the Remifentanil group, the Remifentanil-Propofol group required less remifentanil, had a decreased incidence of postoperative nausea and vomiting, and had a better overall satisfaction level. However, they had an increased incidence of transient apnea and oxygen desaturation. The incidence of apnea was 15% in the Remifentanil group and 52% in the Remifentanil-Propofol group (P < 0.001). All patients were able to move themselves to the stretcher at the end of SWL, and median time to home discharge was <70 min in both groups. Both remifentanil and remifentanil-propofol were useful for PCS during SWL.

IMPLICATIONS: The addition of propofol to remifentanil improves patient satisfaction and decreases postoperative nausea and vomiting. However, it causes more respiratory depression than remifentanil alone. When remifentanil-propofol is used with patient-controlled sedation, appropriate monitoring and a minimum 1–2 min lockout interval is required.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. T. Moerman, L. L. Herregods, M. M. De Vos, E. P. Mortier, and M. M. R. F. Struys
Manual Versus Target-Controlled Infusion Remifentanil Administration in Spontaneously Breathing Patients
Anesth. Analg., March 1, 2009; 108(3): 828 - 834.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. J. Medina, E. M. Galvin, M. Dirckx, P. Banwarie, J. F. H. Ubben, F. J. Zijlstra, J. Klein, and S. J. C. Verbrugge
Remifentanil as a Single Drug for Extracorporeal Shock Wave Lithotripsy: A Comparison of Infusion Doses in Terms of Analgesic Potency and Side Effects
Anesth. Analg., August 1, 2005; 101(2): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Van de Velde, D. Van Schoubroeck, L. E. Lewi, M. A.E. Marcus, J. C. Jani, C. Missant, A. Teunkens, and J. A. Deprest
Remifentanil for Fetal Immobilization and Maternal Sedation During Fetoscopic Surgery: A Randomized, Double-Blind Comparison with Diazepam
Anesth. Analg., July 1, 2005; 101(1): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Mallick, S. Elliot, T. D. Egan, and S. E. Kern
Remifentanil is too potent to be given by bolus
Br. J. Anaesth., August 1, 2004; 93(2): 305 - 306.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. A. Burmeister, T. G. Standl, M. Wintruff, P. Brauer, I. Blanc, and J. Schulte am Esch
Dolasetron prophylaxis reduces nausea and postanaesthesia recovery time after remifentanil infusion during monitored anaesthesia care for extracorporeal shock wave lithotripsy
Br. J. Anaesth., February 1, 2003; 90(2): 194 - 198.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.